- The Rundown Tech
- Posts
- ⚡️ New tech: Lab-grown pet food meat?
⚡️ New tech: Lab-grown pet food meat?
PLUS: Cholesterol gene therapy success
Welcome, Tech enthusiasts.
In an industry-first, startup Bene Meat gained EU approval to sell more nutritious, sustainable lab-grown meat for pet food.
Are you ditch your pet’s brown kibble for a lab-grown alternative? Let’s get into it.
In today’s tech rundown:
First lab-grown 'cultivated' meat approved for pet food
New gene therapy treatment lowers cholesterol
10 new products
7 quick stories
Read time: 3 minutes
TODAY’S HEADLINES
FOOD TECH
Image source: Bene Meat
The Rundown: A Czech startup called Bene Meat Technologies just received the first-ever approval to sell lab-grown meat for pet food in the EU, marking a new production source for the industry.
The details:
Bene Meat received a license from the EU, allowing it to produce and sell pet food made from animal cells grown in a bioreactor.
This cultivated meat aims to be more sustainable, ethical, and consistent compared to traditional pet food.
The final products, made from living animal cells, could launch in 2024 pending deals with manufacturers.
The relevance: With many ditching the burnt brown chow for better options, this novel protein source could improve pet nutrition and lower environmental impact — the question is if prices can remain competitive with other options.
TOGETHER WITH GIST’S SPORTS BIZ
⚡️ Keep up with fast-paced sports business buzz with Gist’s Sports Biz
The Rundown: Dive into the sports business buzz with our free 3x-weekly newsletter, delivering "the gist" on sports business.
Free 3x-weekly newsletter delivering the essence of sports business.
Highlights top stories in women’s and men’s sports business, explaining their significance.
Focus on the thriving business of women’s sports, led and written by women.
Subscribe here, and don't miss the game-changing moves! Join 30,000+ readers in the sports industry and dive into bite-sized, and fun insights.
MEDICAL RESEARCH
Image source: Nature
The Rundown: The first human trial of a precise gene editing technique called base editing successfully reduced LDL cholesterol levels up to 55% in participants but also saw adverse effects — including one death.
The details:
Biotech firm Verve Therapeutics tested their ‘base editing’ treatment VERVE-101, which disables a gene that regulates LDL cholesterol.
10 patients with life-threatening high cholesterol received VERVE-101 injections, showing LDL reductions persisting for 6 months.
However, the trial also saw two concerning adverse events, including one death from a heart attack — raising significant safety questions.
The relevance: Heart disease remains an enormous health burden globally, so potential new options are exciting if proven safe — but safety (and ethical use) of gene editing will be a major hurdle as the tech continues to develop.
NEW PRODUCTS
🤖 Julius AI- Supercharge your data analysis. Turn hours of Excel into minutes with Julius (link)*
👉 Pitch 2.0- Create, share, and analyze presentations easier than ever (link)
📧 MailKing- Make email marketing campaigns a breeze (link)
🖥️ Floutwork- The fastest all-in-one desktop app for productivity (link)
🎥 Descript- A powerful all-in-one video and podcast editing tool using AI (link)
✨ Magic Studio- Create amazing product photos in minutes (link)
✏️ Yaara- Use AI to write proven, high-converting copy (link)
🎵 Mubert- Soundtrack for your content made by AI (link)
🧪 Quizgecko- AI online test and quiz maker (link)
🦾 Fine Tuner- Build AI agents at scale (link)
Browse the most popular tools ever featured with our tool database.
* = This is sponsored content
SNIPPETS
Amazon's Alexa app introduces Map View, a digital mapping feature for easy smart home device management and control.
TikTok introduces a feature to save songs directly to Spotify and Amazon Music, streamlining the music discovery and listening experience.
Uber is implementing measures to identify and prevent users from unfairly manipulating ratings for refunds, enhancing fairness and safety for drivers.
DeepMind's new AI system, GraphCast, is now the most precise 10-day global weather forecasting model.
Juno mission detects surface salts on Ganymede, indicating an underground saltwater ocean.
Microsoft is testing new features for Copilot AI in Windows 11, including an option for it to launch automatically on startup and the ability to resize its panel.
The US military is conducting supersonic B-1 Lancer bomber missions in the Middle East, showcasing its rapid combat power projection capabilities.
SPONSOR US
⚡️ Get your product in front of over 50k+ tech enthusiasts
Our newsletter is read by thousands of tech professionals, investors, engineers, managers, and business owners around the world. Get in touch today.
THAT’S A WRAP
If you have anything interesting to share, please reach out to us by sending us a DM on Twitter: @rowancheung & @therundowntech
How was today's newsletter?Feedback helps us improve! |
Reply